Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Yasuda

Showing results (81-90 of 198) with videos related to

Pageof 20
Sort By:
Plant & Cell Physiology|December 7, 2006
Two novel nuclear genes, OsSIG5 and OsSIG6, encoding potential plastid sigma factors of RNA polymerase in rice: tissue-specific and light-responsive gene expressionYoshiki Kubota, Akio Miyao, Hirohiko Hirochika, et al.
Internal Medicine (Tokyo, Japan)|November 30, 2022
Successful Steroid Treatment of Pembrolizumab-induced Agranulocytosis That Developed after Splenectomy in a Patient with Non-small-cell Lung CancerShinichi Okuzumi, Hirofumi Kamata, Katsura Emoto, et al.
The Journal of Dermatology|March 16, 2017
Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapyHisashi Nomura, Hayato Takahashi, Satsuki Suzuki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patientsIchiro Kawada, Kenzo Soejima, Hideo Watanabe, et al.
Thoracic Cancer|January 20, 2021
HSP90 inhibition overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIsSho Watanabe, Yasushi Goto, Hiroyuki Yasuda, et al.
Cell and Tissue Research|December 13, 2022
Immunohistochemical characterization of transient receptor potential vanilloid types 2 and 1 in a trinitrobenzene sulfonic acid-induced rat colitis model with visceral hypersensitivityKenjiro Matsumoto, Fumika Sugimoto, Toshiki Mizuno, et al.
Respirology Case Reports|June 27, 2025
A Case of PMR-Like irAE Developing After Treatment With Ipilimumab and Nivolumab for Lung CancerRyuichi Utsumi, Hideki Terai, Tetsuya Arai, et al.
JBMR Plus|December 12, 2024
Romosozumab versus bisphosphonates for preventing subsequent vertebral fractures after balloon kyphoplasty: comparison using data from two prospective multicenter studiesHiroyuki Inose, Shinji Takahashi, Masatoshi Teraguchi, et al.
JCO Precision Oncology|September 14, 2020
Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome-Associated Lung AdenocarcinomaKeita Masuzawa, Takanori Asakura, Shinnosuke Ikemura, et al.
Lung Cancer (Amsterdam, Netherlands)|July 9, 2014
Claudin-1 is a novel target of miR-375 in non-small-cell lung cancerSatoshi Yoda, Kenzo Soejima, Junko Hamamoto, et al.
Pageof 20

Showing results (81-90 of 198) with videos related to

Sort By:
Pageof 20
Plant & Cell Physiology|December 7, 2006
Two novel nuclear genes, OsSIG5 and OsSIG6, encoding potential plastid sigma factors of RNA polymerase in rice: tissue-specific and light-responsive gene expressionYoshiki Kubota, Akio Miyao, Hirohiko Hirochika, et al.
Internal Medicine (Tokyo, Japan)|November 30, 2022
Successful Steroid Treatment of Pembrolizumab-induced Agranulocytosis That Developed after Splenectomy in a Patient with Non-small-cell Lung CancerShinichi Okuzumi, Hirofumi Kamata, Katsura Emoto, et al.
The Journal of Dermatology|March 16, 2017
Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapyHisashi Nomura, Hayato Takahashi, Satsuki Suzuki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patientsIchiro Kawada, Kenzo Soejima, Hideo Watanabe, et al.
Thoracic Cancer|January 20, 2021
HSP90 inhibition overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIsSho Watanabe, Yasushi Goto, Hiroyuki Yasuda, et al.
Cell and Tissue Research|December 13, 2022
Immunohistochemical characterization of transient receptor potential vanilloid types 2 and 1 in a trinitrobenzene sulfonic acid-induced rat colitis model with visceral hypersensitivityKenjiro Matsumoto, Fumika Sugimoto, Toshiki Mizuno, et al.
Respirology Case Reports|June 27, 2025
A Case of PMR-Like irAE Developing After Treatment With Ipilimumab and Nivolumab for Lung CancerRyuichi Utsumi, Hideki Terai, Tetsuya Arai, et al.
JBMR Plus|December 12, 2024
Romosozumab versus bisphosphonates for preventing subsequent vertebral fractures after balloon kyphoplasty: comparison using data from two prospective multicenter studiesHiroyuki Inose, Shinji Takahashi, Masatoshi Teraguchi, et al.
JCO Precision Oncology|September 14, 2020
Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome-Associated Lung AdenocarcinomaKeita Masuzawa, Takanori Asakura, Shinnosuke Ikemura, et al.
Lung Cancer (Amsterdam, Netherlands)|July 9, 2014
Claudin-1 is a novel target of miR-375 in non-small-cell lung cancerSatoshi Yoda, Kenzo Soejima, Junko Hamamoto, et al.
Pageof 20